We are creating a future where humanity and the planet can thrive

We are a venture creator, combining available scientific knowledge and founder-type scientists into high-impact ventures

We focus on 5 sectors:

Agriculture
Computation
Climate
Pharma
Education

Restorative Cultivation

Creating ventures to transition agriculture from extractive to regenerative practices.
Learn more

Scaling intelligence

Creating ventures that unlock the potential of computational leverage.
Learn more

Reversing global heating

Creating ventures that optimize for degrees of global heating averted.
Learn more

Curative Therapeutics

Creating ventures to cure diseases, using emerging combinatorial techniques.
Learn more

Developing Venture Scientists

Pioneering dedicated career paths for founder-type scientists and inventors
Learn more
COMPANIES LAUNCHED
56
ACQUISITIONS
1
IN DEVELOPMENT
37
FUNDING ATTRACTED
160
PORTFOLIO VALUATION
500
general
123
Companies created
Energy
260
kgCO2 removed
Agriculture
300
Hectares of sustainable land
pharmaceuticals
24
Drugs under development
Computation
4.000
Hours saved

How We Do It

01

Deep expertise and partnerships with industry leaders

The best founders and a proven methodology

02
03

De-risked ventures and world-class investors

How We create
ventures
Learn more
How We Do It
1
Deep expertise and partnerships with industry leaders
2
The best founders and a proven methodology
3
De-risked ventures and world-class investors

create with us

Are you interested in helping us build a thriving future for humanity and the planet?

content

FEATURED ARTICLES

Recent articles

No items found.
Education
Partnership
SPRIND and Builders Vision Partner with Deep Science Ventures to Enable Entrepreneurship-Focused Doctoral Training
This consortium between Deep Science Ventures, SPRIND and Builder's Vision fully funds five PhDs with total autonomy and research investment to build innovation beyond traditional scientific bottlenecks
11 Mar
2026
No items found.
Pharma
Cancer
Deeptech from scratch #4: redirecting immunity against childhood cancers
In this episode, Kerstin Papenfuss speaks with Aleck Jones, Founder of Kindling Bio, a company developing a new approach to immunotherapy for childhood cancers.
27 Feb
2026
Deeptech from scratch #4: redirecting immunity against childhood cancers
In this episode, Kerstin Papenfuss speaks with Aleck Jones, Founder of Kindling Bio, a company developing a new approach to immunotherapy for childhood cancers.
27 Feb
2026
Deeptech from scratch
Toxicity
FOAK
Power
Bioeconomy
Rare Disease
Plants
Clean Steel
Inflammatory Disease
Water
Science Entrepreneurship
Bioinformatics
Venture Science Doctorate
Outcomes Graph
Partnership
Bioregions
Regenerative
Insurance
Founders
Negative Emissions Technology
Cancer
Science Venture